Related Experiment Video
Updated: Jan 27, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
Ginsenoside Rg3 Inhibits Migration and Invasion of Nasopharyngeal Carcinoma Cells and Suppresses Epithelial
Dingkun Wang1, Cheng Wu2, Dongbo Liu2
1Department of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Abstract:
Nasopharyngeal carcinoma (NPC) is a highly invasive and metastatic head and neck cancer. Distant metastasis becomes the predominant mode of treatment failure in NPC patients. Ginsenoside Rg3 (Rg3), an active pharmaceutical component extracted from traditional Chinese medicine ginseng, shows antitumor effects in various cancers. In this study, we aimed to determine whether Rg3 inhibits the migration and invasion activity of NPC cells and to explore the possible mechanisms. Our results revealed that Rg3 hampers cell migration and invasion in both HNE1 and CNE2 cell lines. A reduced level of matrix metalloproteinase-2 (MMP-2) and MMP-9 was induced by Rg3 treatment. In addition, Rg3 significantly altered the expression of epithelial mesenchymal transition (EMT) markers with increased E-cadherin but decreased Vimentin and N-cadherin expression. Transforming growth factor β- (TGF-β-) induced morphological transition and marker proteins change of EMT were reversed by Rg3. What is more, Rg3 suppressed the expression of EMT-related transcription factors, especially the Zinc Finger E-Box Binding Homeobox 1 (ZEB1). In summary, our data suggested that Rg3 could inhibit migration and invasion of NPC cells. This effect of Rg3 might be mediated through regulating MMP-2 and MMP-9 expressions and suppressing EMT. Thus, Rg3 may be a potentially effective agent for the treatment of NPC.
Insights
Ginsenoside Rg3 (Rg3) inhibits nasopharyngeal carcinoma (NPC) cell migration and invasion. This natural compound may offer a new treatment strategy by suppressing epithelial mesenchymal transition (EMT) and matrix metalloproteinase (MMP) activity.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Nasopharyngeal carcinoma (NPC) is an aggressive head and neck cancer where distant metastasis is a primary cause of treatment failure.
- Ginsenoside Rg3 (Rg3), derived from ginseng, exhibits known antitumor properties across various cancer types.
Purpose of the Study:
- To investigate the inhibitory effects of Rg3 on NPC cell migration and invasion.
- To elucidate the underlying molecular mechanisms by which Rg3 affects NPC progression.
Main Methods:
- Assessed the impact of Rg3 on NPC cell lines (HNE1 and CNE2) regarding migration and invasion.
- Quantified the expression levels of matrix metalloproteinases (MMP-2 and MMP-9).
- Analyzed the expression of epithelial mesenchymal transition (EMT) markers (E-cadherin, Vimentin, N-cadherin) and related transcription factors (ZEB1).
- Evaluated the reversal of TGF-β-induced EMT by Rg3.
Main Results:
- Rg3 significantly inhibited NPC cell migration and invasion in both tested cell lines.
- Rg3 treatment led to reduced levels of MMP-2 and MMP-9.
- Rg3 altered EMT markers, increasing E-cadherin while decreasing Vimentin and N-cadherin.
- Rg3 reversed TGF-β-induced EMT and suppressed the expression of EMT-related transcription factors, notably ZEB1.
Conclusions:
- Ginsenoside Rg3 demonstrates potent inhibition of NPC cell migration and invasion.
- The anti-metastatic effects of Rg3 are likely mediated by the downregulation of MMPs and the suppression of EMT.
- Rg3 represents a promising therapeutic candidate for treating nasopharyngeal carcinoma.
Related Concept Videos
Suctioning the Nasopharyngeal Airway
Equipment Required
Phase Transitions
Cell Migration
Cell Migration
Feedback Inhibition
Properties of Transition Metals

